<html>
<head>
<title>Short Summary </title>
<meta http-equiv="Content-Type" content="text/html; charset=iso-8859-1">
</head>

<body bgcolor="#B6B6B6">
<table width="777" border="0" cellpadding="0" cellspacing="0" bgcolor="#2E5C5C" align="center">
  <tr> 
    <td height="64" valign="top" colspan="2"> 
      <table width="100%" border="0" cellpadding="0" cellspacing="0" bgcolor="000000" align="center">
        <tr> 
          <td width="750" height="50" valign="middle"> 
            <div align="center"> 
              <p><a name="Top"></a></p>
            </div>
          </td>
        </tr>
      </table>
    </td>
  </tr>
  <tr> 
    <td height="26" width="54"></td>
    <td valign="top" width="723" height="26"> 
      <table width="100%" border="0" cellpadding="0" cellspacing="0">
        <tr> 
          <td width="723" height="37"><a href="SS_ARB.html"><img src="../Assets/SS1.gif" width="165" height="37" align="baseline" name="Short_Summary" border="0"></a><a href="ACP_ARB.html"><img src="../Assets/SS2.gif" width="142" height="37" name="ACP" border="0"></a><a href="CE_ARB.html"><img src="../Assets/SS3.gif" width="140" height="37" name="Clinical_Evidence" border="0"></a><a href="JNC6_ARB.html"><img src="../Assets/SS4.gif" width="77" height="37" name="JNC_VI" border="0"></a><a href="PM_ARB.html"><img src="../Assets/SS5.gif" width="78" height="37" name="PubMed" border="0"></a><a href="VA_ARB.html"><img src="../Assets/SS6.gif" width="121" height="37" border="0"></a></td>
        </tr>
      </table>
    </td>
  </tr>
  <tr> 
    <td height="44" width="54"></td>
    <td valign="top" height="44"> 
      <table width="100%" border="0" cellpadding="0" cellspacing="0">
        <tr> 
          <td width="723" height="38"><img src="../Assets/SSheader.gif" width="330" height="50" align="baseline"><img src="../Assets/SSheader2.gif" width="393" height="50" align="baseline"></td>
        </tr>
      </table>
    </td>
  </tr>
  <tr> 
    <td height="469" width="54"></td>
    <td valign="top"> 
      <table width="100%" border="0" cellpadding="0" cellspacing="0">
        <tr> 
          <td width="746" height="469" bgcolor="ebfbfe"> 
            <div align="center"><br>
              <br>
              <table width="88%" border="0">
                <tr>
                  <td> <b></b> 
                    <p><font color="660033" size="2" face="Verdana, Arial, Helvetica, sans-serif">Because 
                      they are not associated with the intractable dry cough seen 
                      in some patients taking ACE inhibitors, angiotensin receptor 
                      blockers are indicated in patients who require an ACE inhibitor 
                      but who cannot tolerate it due to drug-induced dry cough.(Therapeutics 
                      Letter, issue 28, January/February/March 1999)</font></p>
                    <p><font color="660033" size="2" face="Verdana, Arial, Helvetica, sans-serif"><b>Angiotensin-II 
                      Receptor Antagonists: Their Place in Therapy</b><br>
                      JULIENNE K. KIRK, PHARM.D., <br>
                      Wake Forest University School of Medicine, Winston-Salem, 
                      North Carolina </font></p>
                    <p><font color="660033" size="2" face="Verdana, Arial, Helvetica, sans-serif">Angiotensin-II 
                      receptor antagonists are well tolerated. Cough occurs much 
                      less often with these agents than with angiotensin-converting 
                      enzyme inhibitors, and they do not adversely affect lipid 
                      profiles or cause rebound hypertension after discontinuation. 
                      Clinical trials indicate that angiotensin-II receptor antagonists 
                      are effective and safe in the treatment of hypertension. 
                      </font></p>
                    <p><font color=#660033 face="Verdana, Arial, Helvetica, sans-serif" 
size=-1>Andersen 2000<br>
                      </font></p>
                    <ul>
                      <li><font color=#660033 face="Verdana, Arial, Helvetica, sans-serif" 
  size=-1>16 diabetic pts with persistent albuminuria and office BP&gt;145/80. 
                        </font> 
                      <li><font color=#660033 face="Verdana, Arial, Helvetica, sans-serif" 
  size=-1>randomized, double blind, cross over trial of losartan 50, 100, enalapril 
                        10, 20 and placebo-2 months each outcome.</font> 
                      <li><font color=#660033 face="Verdana, Arial, Helvetica, sans-serif" 
  size=-1>24h BP- both reduced BP significantly as compared to placebo proteinuria 
                        - both reduced albuminuria significantly as compared to 
                        placebo GFR- no difference between losartan, enalapril 
                        and placebo. </font> 
                      <li><font color=#660033 face="Verdana, Arial, Helvetica, sans-serif" 
  size=-1>Enalapril was associated with increased potassium levels as compared 
                        to placebo. </font></li>
                    </ul>
                    <p><font color=#660033 face="Verdana, Arial, Helvetica, sans-serif" size=-1>JNC 
                      6 page 29, 1st column 2nd paragraph.</font></p>
                    <p><font color=#660033 face="Verdana, Arial, Helvetica, sans-serif" size=-1>"... 
                      angiotensin recptor blockers should be used primarily in 
                      patients in whom ACE inhibitors are indicated</font></p>
                    <p align="right"><a href="#Top"><img src="../Assets/Top.gif" width="76" height="37" border="0"></a></p>
</td>
                </tr>
              </table>
              <br>
            </div>
          </td>
        </tr>
      </table>
    </td>
  </tr>
  <tr> 
    <td height="28" width="54"></td>
    <td valign="top"> 
      <table width="100%" border="0" cellpadding="0" cellspacing="0" bgcolor="#55C6C6">
        <tr> 
          <td width="723" height="28" bgcolor="73babd"> 
            
          </td>
        </tr>
      </table>
    </td>
  </tr>
</table>
</body>
</html>
